Adenosinergic Axis and Immune Checkpoint Combination Therapy in
Tumor:A New Perspective for Immunotherapy Strategy
Zhaoyun Liu1*, Xiaohan Liu1*, Hongli
Shen1, Xintong Xu1, Xianghong
Zhao1, Rong Fu1
Addresses:1 Department of Hematology, Tianjin Medical
University General Hospital, 154 Anshan Street, Heping District, Tianjin
300052, PR China.
*These authors contributed equally to this manuscript.
Corresponding author: Rong Fu
Department of Hematology, Tianjin Medical University General Hospital,
154 Anshan Street, Heping District, Tianjin 300052, PR China. Telephone:
(086) 02260817181. Fax number: (086) 02260817181. E-mail:furong8369@tmu.edu.cn
The authors declare no potential conflicts of interest.
This work was supported by the National Natural Science Foundation of
China Youth Project (grant no. 81900131), the National Natural Science
Foundation of China Youth Project (grant no. 8210010129), the Tianjin
Municipal Natural Science Foundation (grant no. 18JCQNJC80400), the
Tianjin Education Commission Research Project (grant no. 2018KJ043), the
Tianjin Education Commission Research Project (grant no. 2018KJ045), and
the Tianjin Science and Technology Planning Project (no.
20YFZCSY00060).Tianjin Municipal Health Commission Youth Project(grant
no. TJWJ2021QN001);Medjaden Academy & Research Foundation for Young
Scientists (Grant No. MJR20221011);Tianjin Key Medical
Discipline(Specialty) Construction project.